Accueil / Communiqués / MAASTRO Clinic Begins Treatments with Mevion Proton System

MAASTRO Clinic Begins Treatments with Mevion Proton System

Friday, February 8th 2019 at 2:52pm UTC

MAASTRO Clinic is the first HYPERSCAN Pencil Beam Scanning Center in
Europe.

LITTLETON, Mass.–(BUSINESS WIRE)– The Zuid-Oost
Nederland Protonen Therapie Centrum
, (ZON-PTC) at the MAASTRO
Clinic
in Maastricht, the Netherlands has become the first center in
Europe to provide proton therapy to patients utilizing a compact,
single-room system. The center features the MEVION S250i Proton Therapy
System® with HYPERSCAN® Pencil Beam Scanning and an integrated in-room
cone beam CT system, the ImagingRing™*
from medPhoton.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20190208005291/en/

Team members from ZON-PTC and Mevion gather to celebrate the first patient treatment. (Photo: Busine ...

Team members from ZON-PTC and Mevion gather to celebrate the first patient treatment. (Photo: Business Wire)

Proton therapy is a superior form of radiation therapy that can reduce
the amount of unnecessary radiation exposure to surrounding healthy
tissue and sensitive organs at risk. HYPERSCAN
Pencil Beam Scanning
improves on these benefits by utilizing an
adaptive multi-leaf collimator to sharpen the beam and enable a more
precise and conformal dose to the tumor than ever before.

“Proton therapy is an important tool in cancer treatment, and we are
excited to now offer this advanced form of proton therapy to patients
who need it most,” said Geert Bosmans, managing director of ZON-PTC.

Mevion’s streamlined installation allowed the clinicians at ZON-PTC to
begin treating patients in less than a year from cyclotron delivery.
Moreover, with the industry’s smallest footprint, the proton system was
directly embedded into the radiation therapy department in a narrow
space between two clinical buildings. This enables ZON-PTC to share
existing resources and expand the treatment options available at the
MAASTRO Clinic.

“This opening is part of Mevion’s mission to provide global access to
this advanced cancer-fighting tool,” said Tina Yu, CEO of Mevion. “We
are very proud to partner with MAASTRO Clinic to open the ZON-PTC, and
we look forward to many years of collaboration and research.”

Adoption of proton therapy has been expanding rapidly because of the
development of compact proton therapy systems. Today, new proton therapy
systems are almost exclusively compact single-room systems. Mevion was
the first company to innovate this new approach to proton therapy and
provides the most compact system available today.

*The ImagingRing from medPhoton is 510(k) pending and has not been
cleared by the US FDA for clinical use.

About Mevion Medical Systems

Mevion Medical Systems, Inc. is the leading provider of compact proton
therapy systems for use in radiation treatment for cancer patients.
Mevion is based in Littleton, Massachusetts, with a presence in Europe
and China. For more information, please visit www.mevion.com.

Follow Mevion on Twitter: https://twitter.com/mevionmedical

Connect with Mevion on LinkedIn: https://www.linkedin.com/company/mevion-medical-systems

Contacts

Mevion
Melanie Benton
978-540-1551
mbenton@mevion.com

Source: Mevion Medical Systems, Inc.


Voir aussi

Maverick Therapeutics to Unveil Pre-Clinical Data on Novel COBRATM Platform at American Association for Cancer Research 2019 Annual Meeting

Saturday, March 30th 2019 at 12:00pm UTC – Pre-clinical Data Characterize the Conditional and Potent …